PERISCOPE SITELINE

Empirican Group Inc.

Application Filed: 2015-06-23

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	86671732
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Anne M. Schneiderman
Attorney Docket Number	278091
Law Office Assigned	N10
Employee Name	RITTNER, HANNO I

Timeline

2015-06-23	Application Filed
2016-01-19	Published for Opposition
2016-03-15	Location: INTENT TO USE SECTION
2017-04-17	Abandon
2017-04-17	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	EMPIRICAN GROUP INC.
Address	77 GOODELL STREET SUITE 440 BUFFALO DE 14203
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

ANNE M. SCHNEIDERMAN
Harris Beach
333 W Washington St Ste 200
Syracuse, NY 13202-5202

Good, Services, and Codes

International Codes:	9
U.S. Codes:	021,023,026,036,038
International Codes:	35
U.S. Codes:	100,101,102
International Codes:	42
U.S. Codes:	100,101
International Codes:	44
U.S. Codes:	100,101
International Codes:	45
U.S. Codes:	100,101

Type Code	Type
GS0091	Computer software, for use with medical clinical trial subject monitoring equipment, for receiving, processing, analyzing, transmitting, validating and displaying data; Computer software for controlling and managing patient medical clinical trial information; Computer software for controlling and managing patient medical information for clinical trials; Computer software for controlling and managing point-of-contact electronic data capture of patient visits for clinical trials; Computer software for use by clinical trial subjects for providing clinical trial information, for scheduling appointments and clinical trial visits; Computer software for use by clinical trial subjects for reporting health information, adverse events and side effects of treatment and medication; Computer software for use by clinical trial subjects for clinical trial-related education and information; Computer software for use on a mobile platform for tracking clinical trial subject enrollment, status and adverse/side effects of treatment and medication, metrics on performance by site of clinical trial, and real-time tracking of adverse events

Type Code

Type

GS0091

Computer software, for use with medical clinical trial subject monitoring equipment, for receiving, processing, analyzing, transmitting, validating and displaying data; Computer software for controlling and managing patient medical clinical trial information; Computer software for controlling and managing patient medical information for clinical trials; Computer software for controlling and managing point-of-contact electronic data capture of patient visits for clinical trials; Computer software for use by clinical trial subjects for providing clinical trial information, for scheduling appointments and clinical trial visits; Computer software for use by clinical trial subjects for reporting health information, adverse events and side effects of treatment and medication; Computer software for use by clinical trial subjects for clinical trial-related education and information; Computer software for use on a mobile platform for tracking clinical trial subject enrollment, status and adverse/side effects of treatment and medication, metrics on performance by site of clinical trial, and real-time tracking of adverse events

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2015-06-26	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2015-06-29	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2015-09-28	3 DOCK D:Assigned to Examiner
PRIORITY ACTION WRITTEN	2015-09-29	4 CPRA R:Renewal
PRIORITY ACTION E-MAILED	2015-09-29	5 GPRA F:First Action
NOTIFICATION OF PRIORITY ACTION E-MAILED	2015-09-29	6 GPRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2015-11-25	7 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2015-11-25	8 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2015-11-26	9 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2015-11-27	10 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2015-12-30	11 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2016-01-19	12 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2016-01-19	13 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2016-03-15	14 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2016-09-08	15 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2016-09-08	16 EXT1 S:
EXTENSION 1 GRANTED	2016-09-08	17 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2016-09-10	18 EXRA E:E-Mail
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2017-03-22	19 ASGN I:Incoming Correspondence
ABANDONMENT - NO USE STATEMENT FILED	2017-04-17	20 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2017-04-17	21 MAB6 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.